Back to Search Start Over

Patent Issued for Implantable scaffolds for treatment methods of sinusitus (USPTO 12064339).

Source :
Pharma Business Week; 9/9/2024, p4491-4491, 1p
Publication Year :
2024

Abstract

The article reports that Lyra Therapeutics Inc. has received a patent for implantable scaffolds designed to treat chronic rhinosinusitis (CRS) by providing localized, sustained drug delivery. Topics discussed include the challenges of current CRS treatments, the advantages of the new scaffolds in reducing the need for surgery, and the potential for improved post-surgical care.

Details

Language :
English
ISSN :
15436675
Database :
Complementary Index
Journal :
Pharma Business Week
Publication Type :
Periodical
Accession number :
179480639